Effect of Liraglutide on Weight Loss in Patients Who Have Undergone Revisional Bariatric Surgeries.
Condition:   Morbid Obesity Intervention:   Drug: Liraglutide Pen Injector [Saxenda] Sponsor:   General Committee of Teaching Hospitals and Institutes, Egypt Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 17, 2022 Category: Research Source Type: clinical trials